Company Name or Ticker Symbol
Search for other Categories

Exelixis, Inc.  (EXEL)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories

EXEL's Revenue Year on Year Growth by Quarter and Year

Exelixis,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
EXEL Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 77.58 9.94 7.35 0.70
III Quarter September 62.19 9.85 6.29 5.47
II Quarter June 36.25 7.99 6.56 11.86
I Quarter March 15.43 9.39 4.91 7.81
FY   191.45 37.17 25.11 25.84

Financial Statements
Exelixis,'s forth quarter 2016 Revenue $ 77.58 millions EXEL's Income Statement
Exelixis,'s forth quarter 2015 Revenue $ 9.94 millions Quarterly EXEL's Income Statement
EXEL's Growth by Division See EXEL's Growth by Segment

EXEL Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 680.49 % 35.24 % 950 % -94.74 %
III Quarter September 531.37 % 56.6 % 14.99 % -29.96 %
II Quarter June 353.69 % 21.8 % -44.69 % -35.93 %
I Quarter March 64.32 % 91.24 % -37.13 % -
FY   415.07 % 48.03 % -2.83 % -

EXEL Revenue Growth Comment
Exelixis, Inc. achieved in the forth quarter, above Company average Revenue surge of 680.49% year on year, to $ 77.58 millions.

Among companies who have reported forth quarter results in the Medical Laboratories industry only one Company has achieved higher year on year Revenue results in the forth quarter. While Exelixis, Inc.' s Revenue doubling of 680.49% ranks overall at the positon no. 49 in the forth quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #14
S&P 500 #49
Revenue Y/Y Growth Statistics
High Average Low
945.95 % 189.49 % -91 %
(Jan 02 2015)   (Dec 27 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EXEL's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EXEL's Competitors
Revenue Growth for Exelixis,'s Suppliers
Revenue Growth for EXEL's Customers

You may also want to know
EXEL's Annual Growth Rates EXEL's Profitability Ratios EXEL's Asset Turnover Ratio EXEL's Dividend Growth
EXEL's Roe EXEL's Valuation Ratios EXEL's Financial Strength Ratios EXEL's Dividend Payout Ratio
EXEL's Roa EXEL's Inventory Turnover Ratio EXEL's Growth Rates EXEL's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Dec 30 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 30 2016
Psivida Corp.  1,035.17 %$ 1,035.171 millions
Arena Pharmaceuticals Inc  1,001.46 %$ 1,001.458 millions
Innovus Pharmaceuticals, Inc.  863.00 %$ 863.000 millions
Dynavax Technologies Corp  814.74 %$ 814.745 millions
Exact Sciences Corp  589.15 %$ 589.154 millions
Sophiris Bio Inc.  550.00 %$ 550.000 millions
Juno Therapeutics, Inc.  409.47 %$ 409.465 millions
Eagle Pharmaceuticals, Inc.  346.31 %$ 346.315 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
SBBX's Profile
Stock Price
SBBX's Financials
SBBX's Expectations
Business Description
Charts & Quotes
SBBX's News
SBBX's Competitors
Customers & Markets
Economic Indicators
SBBX's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com